SEC Form 4 insider trading filings tracked in real time from EDGAR

Abate Kristin — Chief Accounting Officer

Insider trading activity for Abate Kristin sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Accounting Officer
  • Company: Karyopharm Therapeutics Inc.
  • Total insider trades: 4
  • Total buy volume: $0
  • Total sell volume: $991
  • Last trade: Oct 2, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Oct 1, 2026 Abate Kristin KPTI Karyopharm Therapeutics Inc. SELL 378 $450
Sep 1, 2026 Abate Kristin KKPTI KKPTI SELL 19 $38
May 14, 2026 Abate Kristin KPTI Karyopharm Therapeutics Inc. SELL 53 $504
May 13, 2026 Abate Kristin KPTI Karyopharm Therapeutics Inc. OTHER 121 N/A

← All executives · Full trades feed